TY - JOUR
AU - W. Liao
AU - C. Coupland
AU - J. Burchardt
AU - D. Baldwin
AU - F. Gleeson
AU - J. Hippisley-Cox
AD - Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; School of Medicine, University of Nottingham, Nottingham, UK.
School of Medicine, University of Nottingham, Nottingham, UK; Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Department of Oncology, University of Oxford, Oxford, UK.
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: julia.hippisley-cox@phc.ox.ac.uk.
AN - 37030308
BT - Lancet Respir Med
DO - 10.1016/s2213-2600(23)00050-4
DP - NLM
ET - 2023/04/09
LA - eng
N1 - 2213-2619
Liao, Weiqi
Coupland, Carol A C
Burchardt, Judith
Baldwin, David R
DART initiative
Gleeson, Fergus V
Hippisley-Cox, Julia
Journal Article
England
Lancet Respir Med. 2023 Apr 5:S2213-2600(23)00050-4. doi: 10.1016/S2213-2600(23)00050-4.
PY - 2023
SN - 2213-2600
T2 - Lancet Respir Med
TI - Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models
ER -